BiondVax Pharmaceuticals Ltd. Sponsored ADR Stock
BiondVax Pharmaceuticals Ltd. Sponsored ADR Stock price
Key metrics
| Market capitalization | $2.39m |
| Enterprise Value | $20.00m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| EV/Sales (TTM) EV/Sales | 71.43 |
| P/S ratio (TTM) P/S ratio | 8.54 |
| P/B ratio (TTM) P/B ratio | negative |
| Revenue (TTM) Revenue | $280.00k |
| EBIT (operating result TTM) EBIT | $-7.92m |
Is BiondVax Pharmaceuticals Ltd. Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
BiondVax Pharmaceuticals Ltd. Sponsored ADR Stock Analysis
Analyst Opinions
1 Analyst has issued a forecast BiondVax Pharmaceuticals Ltd. Sponsored ADR:
Analyst Opinions
1 Analyst has issued a forecast BiondVax Pharmaceuticals Ltd. Sponsored ADR:
Financial data from BiondVax Pharmaceuticals Ltd. Sponsored ADR
| Jun '24 |
+/-
%
|
||
| Revenue | 0.28 0.28 |
-
|
|
| Gross Profit | -1.04 -1.04 |
-
|
|
| EBITDA | -7.04 -7.04 |
-
|
EBIT (Operating Income) EBIT | -7.92 -7.92 |
31%
31%
|
| Net Profit | -3.75 -3.75 |
59%
59%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about BiondVax Pharmaceuticals Ltd. Sponsored ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases. It works on M-001, a synthetic peptide-based protein targeting both seasonal and pandemic strains of the influenza virus. The company was founded by Ron Babecoff and Rami Epstein on July 22, 2003 and is headquartered in Jerusalem, Israel.
| Head office | Israel |
| CEO | Amir Reichman |
| Employees | 31 |
| Founded | 2003 |
| Website | www.scinai.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
